| Symbol | ACB |
|---|---|
| Name | AURORA CANNABIS INC |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medicinal Chemicals & Botanical Products |
| Address | 2207 90B STREET SW, EDMONTON, A0 T6X 1V8 |
| Telephone | 604-362-5207 |
| Fax | — |
| — | |
| Website | https://www.auroramj.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001683541 |
| Description | Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael 71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries. Additional info from NASDAQ: |
Aurora Cannabis Urges Shareholders to REJECT Curaleafs Hostile Bid, Warning that it is Inadequate, Undervalues Aurora and Puts Shareholder Value and Future Upside at Risk
Read moreNew Form F-X - AURORA CANNABIS INC <b>Filed:</b> 2026-09-02 <b>AccNo:</b> 0001104659-26-104482 <b>Size:</b> 21 KB
Read moreNew Form SC14D9F - AURORA CANNABIS INC <b>Filed:</b> 2026-09-02 <b>AccNo:</b> 0001104659-26-104464 <b>Size:</b> 2 MB
Read moreNew Form SC14D1F/A - AURORA CANNABIS INC <b>Filed:</b> 2026-08-27 <b>AccNo:</b> 0001104659-26-102376 <b>Size:</b> 118 KB
Read moreAurora Cannabis Furthers Global Medical Cannabis Growth with Accretive Acquisition of Internode Pharma Limited and HAP Pharma Limited, Expanding Distribution Access to the UK Medical Cannabis Market
Read moreAurora Cannabis Furthers Global Medical Cannabis Growth with Accretive Acquisition of Internode Pharma Limited and HAP Pharma Limited, Expanding Distribution Access to the UK Medical Cannabis Market
Read moreAURORA CANNABIS INC. URGES SHAREHOLDERS TO TAKE NO ACTION AT THIS TIME IN RESPECT TO THE UNSOLICITED TAKE-OVER BID BY CURALEAF HOLDINGS, INC.
Read moreAURORA CANNABIS INC. URGES SHAREHOLDERS TO TAKE NO ACTION AT THIS TIME IN RESPECT TO THE UNSOLICITED TAKE-OVER BID BY CURALEAF HOLDINGS, INC.
Read moreNew Form SC14D1F - AURORA CANNABIS INC <b>Filed:</b> 2026-08-18 <b>AccNo:</b> 0001104659-26-098277 <b>Size:</b> 157 KB
Read moreAURORA CANNABIS INC. RESPONDS TO PRESS RELEASE OF CURALEAF HOLDINGS, INC. REGARDING INTENTION TO LAUNCH UNSOLICITED TAKE-OVER BID
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT03522467 | Cannabis Oil for Pain Effectiveness | Phase2 | Cancer | Unknown | 2018-07-25 | 2020-09-01 | ClinicalTrials.gov |
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| MRCP001 | Other | Phase PHASE2 | Cancer | UNKNOWN | NCT03522467 |
| MRCP001 | DRUG | Phase PHASE2 | Cancer | UNKNOWN | NCT03522467 |